
Indee Labs
Indee Labs is a YC Winter 2017 (W17) company. Based in Berkeley, CA, USA. Team of 5.
About Indee Labs
Summary
Indee Labs builds Hydropore, a microfluidic vortex shedding platform that delivers nucleic acids, proteins, and gene-editing complexes into T cells without viral vectors or electroporation. Biotech and cell therapy companies use it across discovery, development, and manufacturing to engineer immune cells at scale while preserving cell viability and function. The system replaces viral transduction and traditional transfection methods, which are the bottleneck steps in T cell immunotherapy workflows.
Business model
Hydropore devices are available to purchase directly for research use, with a clinical manufacturing system in development.
Go-to-market
Biotech and cell therapy companies are the buyers; they access the technology through direct ordering of the Hydropore device for research use, with a distribution partnership covering the Chinese market.
From the Y Combinator listing
Enabling T cell immunotherapy discovery, development and manufacturing
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- Berkeley, CA, USA
- 5
- Active
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works